Twist Bioscience Corp. (TWST)
124.72
-3.99
(-3.10%)
USD |
NASDAQ |
Sep 04, 16:00
124.20
-0.52
(-0.42%)
Pre-Market: 20:00
Twist Bioscience Research and Development Expense (Quarterly) : 18.02M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 18.02M |
| March 31, 2026 | 19.70M |
| December 31, 2025 | 17.13M |
| September 30, 2025 | 17.01M |
| June 30, 2025 | 18.05M |
| March 31, 2025 | 23.92M |
| December 31, 2024 | 21.31M |
| September 30, 2024 | 21.13M |
| June 30, 2024 | 22.47M |
| March 31, 2024 | 24.15M |
| December 31, 2023 | 23.10M |
| September 30, 2023 | 23.74M |
| June 30, 2023 | 24.53M |
| March 31, 2023 | 27.38M |
| December 31, 2022 | 31.24M |
| September 30, 2022 | 29.61M |
| June 30, 2022 | 36.84M |
| March 31, 2022 | 31.23M |
| December 31, 2021 | 22.63M |
| September 30, 2021 | 19.44M |
| Date | Value |
|---|---|
| June 30, 2021 | 19.84M |
| March 31, 2021 | 15.79M |
| December 31, 2020 | 14.00M |
| September 30, 2020 | 11.64M |
| June 30, 2020 | 10.44M |
| March 31, 2020 | 10.63M |
| December 31, 2019 | 10.30M |
| September 30, 2019 | 10.50M |
| June 30, 2019 | 9.007M |
| March 31, 2019 | 8.907M |
| December 31, 2018 | 7.273M |
| September 30, 2018 | 6.065M |
| June 30, 2018 | 5.268M |
| March 31, 2018 | 4.711M |
| December 31, 2017 | 4.303M |
| September 30, 2017 | 4.851M |
| June 30, 2017 | 5.277M |
| March 31, 2017 | 4.709M |
| December 31, 2016 | 4.332M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Beam Therapeutics, Inc. | 95.10M |
| Intellia Therapeutics, Inc. | 80.50M |
| Prime Medicine, Inc. | 33.40M |
| Absci Corp. | 22.62M |
| Generate Biomedicines, Inc. | 61.12M |